---

ligand → CapableOf → disclaim any intent	0.68
bivalent ligand (subgroup of ligand) → CapableOf → target gpcrs	0.68
bound ligand (subgroup of ligand) → CapableOf → generate an intensity signal	0.68
structure (aspect of ligand) → ReceivesAction → designed to optimize stability	0.68
structure (aspect of ligand) → HasProperty → identical	0.67
ligand → ReceivesAction → prepared	0.67
ligand → ReceivesAction → removed	0.64
structure (aspect of ligand) → ReceivesAction → solved by molecular replacement	0.62
ligand → ReceivesAction → selected	0.61
ligand → CapableOf → bind to receptor	0.59
ligand → HasProperty → active	0.58
ligand → CapableOf → act as a lewis base	0.54
ligand → ReceivesAction → bound	0.53
ligand → CapableOf → established multiple alliances	0.52
ligand → HasProperty → neutral	0.51
ligand → CapableOf → bind to protein	0.50
ligand → ReceivesAction → synthesized	0.47
ligand → CapableOf → activate receptor	0.47
ligand → CapableOf → create cash flows	0.46
structure (aspect of ligand) → ReceivesAction → determined	0.45
ligand → ReceivesAction → released	0.45
ligand → HasProperty → identical	0.44
structure (aspect of ligand) → ReceivesAction → shown in figure	0.44
ligand → ReceivesAction → entitled to royalty	0.44
ligand → CapableOf → established other business relationships	0.42
ligand → CapableOf → interact with receptor	0.42
ligand → ReceivesAction → bound to dna	0.41
ligand → ReceivesAction → eligible to receive annual platform access payments	0.41
ligand → HasProperty → tetradentate	0.41
ligand → IsA → organic compounds	0.40
ligand → ReceivesAction → referred	0.40
ligand → CapableOf → established merck	0.39
ligand → CapableOf → established spectrum pharmaceuticals	0.39
ligand → ReceivesAction → docked	0.39
ligand → CapableOf → bind to a central metal atom	0.38
ligand → CapableOf → established pfizer	0.38
ligand → CapableOf → established eli lilly	0.38
ligand → ReceivesAction → identified	0.38
ligand → CapableOf → experience delay	0.38
ligand → ReceivesAction → expressed on dendritic cells	0.38
ligand → IsA → substance	0.37
ligand → CapableOf → bind to polypeptide	0.37
ligand → CapableOf → form complex	0.37
ligand → ReceivesAction → eligible to receive a tiered royalty	0.37
ligand → CapableOf → attach to metal	0.37
ligand → CapableOf → experience significant costs	0.37
ligand → HasProperty → important	0.37
ligand → CapableOf → bind through two sites	0.36
ligand → CapableOf → induce conformational change	0.36
ligand → ReceivesAction → present on solid support in immobilized form	0.36
ligand → ReceivesAction → eligible to receive annual access payments	0.36
ligand → ReceivesAction → expressed	0.36
structure (aspect of ligand) → ReceivesAction → obtained	0.36
ligand → CapableOf → vary in size	0.35
ligand → CapableOf → receive revenue	0.35
ligand → HasProperty → weak	0.35
ligand → CapableOf → bind to the polymer	0.35
ligand → ReceivesAction → displayed in stick	0.34
ligand → HasProperty → specific	0.34
ligand → CapableOf → induce g protein-mediated signalling	0.34
ligand → ReceivesAction → charged	0.32
ligand → ReceivesAction → anchored to the plasma membrane	0.32
ligand → HasProperty → rigid	0.32
ligand → ReceivesAction → detected	0.32
ligand → ReceivesAction → entitled to revenue	0.32
ligand → HasA → diverse asset portfolio	0.30
ligand → HasProperty → bidentate	0.30
ligand → CapableOf → produce signal	0.30
ligand → HasProperty → absent	0.30
ligand → ReceivesAction → retrieved	0.30
ligand → CapableOf → hold a 1% ownership interest	0.30
ligand → HasProperty → selective	0.30
ligand → CapableOf → receive a license fee	0.30
ligand → CapableOf → bind to tlrs	0.30
ligand → ReceivesAction → removed by a chemical reaction	0.30
ligand → ReceivesAction → employed	0.30
structure (aspect of ligand) → ReceivesAction → retrieved	0.29
structure (aspect of ligand) → UsedFor → docking	0.29
structure (aspect of ligand) → ReceivesAction → superimposed	0.29
ligand → CapableOf → exhibit enzymatic properties	0.28
ligand → ReceivesAction → contacted with suitable substrate	0.28
ligand → ReceivesAction → tagged with one or more tags	0.28
ligand → ReceivesAction → bound to many different carriers	0.28
ligand → HasProperty → adjacent	0.28
ligand → CapableOf → bind to dna double helix	0.28
ligand → CapableOf → pay 17.5 million	0.28
ligand → ReceivesAction → entitled to receive a 2.5% royalty	0.28
ligand → HasProperty → hydrophobic	0.28
ligand → ReceivesAction → isolated	0.28
ligand → CapableOf → induce -arrestin recruitment independently40,41	0.28
ligand → ReceivesAction → tested	0.28
ligand → ReceivesAction → substituted	0.28
ligand → CapableOf → interact with corresponding molecular antennae	0.28
ligand → CapableOf → bind to notch receptors	0.28
ligand → ReceivesAction → indicated in cyan	0.28
ligand → ReceivesAction → indicated in green	0.28
ligand → HasProperty → stable	0.28
ligand → CapableOf → engage in wrongful acts	0.28
ligand → ReceivesAction → shown on the viewer	0.28
ligand → HasProperty → unknown	0.27
ligand → CapableOf → form octahedron	0.25
ligand → CapableOf → activate rage	0.25
ligand → ReceivesAction → required to consolidate the llc	0.25
ligand → ReceivesAction → characterized by nmr	0.25
ligand → ReceivesAction → directed against respective full-length peptide	0.25
ligand → ReceivesAction → characterized by elemental analysis	0.25
ligand → CapableOf → chelate agent	0.25
ligand → CapableOf → fund as part of the agreement	0.25
ligand → HasProperty → visible	0.25
ligand → CapableOf → receive an ownership position	0.25
ligand → CapableOf → interact with domain	0.25
ligand → ReceivesAction → labelled	0.25
ligand → ReceivesAction → cleaved	0.25
ligand → HasProperty → co	0.25
ligand → CapableOf → reserved such shares of common stock	0.25
ligand → HasA → current commitments	0.25
ligand → ReceivesAction → required to make in excess of the principal amount	0.25
ligand → CapableOf → expect to enter into warrant transactions	0.25
ligand → CapableOf → bind to enzyme	0.25
ligand → ReceivesAction → characterized by ir	0.25
ligand → ReceivesAction → dismissed	0.25
ligand → HasA → option	0.25
ligand → CapableOf → established astrazeneca	0.25
ligand → HasProperty → up-regulated	0.25
ligand → CapableOf → induce change	0.25
ligand → CapableOf → comprise two major specificity subclasses	0.25
ligand → ReceivesAction → compartmentalized	0.25
ligand → CapableOf → dictate ligand substitution rates	0.25
ligand → CapableOf → dictate the reactivity of the ligands	0.25
ligand → CapableOf → established bristol-myers squibb	0.25
ligand → ReceivesAction → expressed in the epidermis	0.25
ligand → HasProperty → insoluble	0.25
ligand → ReceivesAction → reacted with nicl2	0.25
ligand → ReceivesAction → obtained by kugelrohr distillation	0.25
ligand → CapableOf → bind in alternative binding mode	0.25
ligand → HasProperty → labile	0.25
ligand → ReceivesAction → retained in the bathing medium	0.25
ligand → ReceivesAction → identified at mw	0.25
ligand → CapableOf → bind to natriuretic peptide	0.25
ligand → ReceivesAction → produced by macrophage	0.25
ligand → ReceivesAction → produced by endothelial cells	0.25
ligand → HasA → reactive functional group	0.25
ligand → ReceivesAction → prepared for docking	0.25
ligand → ReceivesAction → based on sds	0.25
ligand → ReceivesAction → constituted by a cyclopentadienyl group	0.25
ligand → ReceivesAction → demonstrated in human colon cancer cell lines	0.25
ligand → CapableOf → interact with structure	0.25
structure (aspect of ligand) → HasA → ligand	0.25
structure (aspect of ligand) → HasProperty → unknown	0.25
structure (aspect of ligand) → ReceivesAction → removed	0.25
structure (aspect of ligand) → ReceivesAction → confirmed by x-ray crystallography	0.25
structure (aspect of ligand) → CapableOf → follow the scissor theory	0.25
structure (aspect of protein) → HasA → ligand	0.25
ligand → HasProperty → successful	0.22
ligand → HasProperty → soluble	0.16
ligand → CapableOf → earned a $1.5 million milestone payment	0.16
ligand → ReceivesAction → lost	0.16
ligand → CapableOf → interfere with current conduction	0.16
ligand → CapableOf → expend significant resources	0.16